These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 32789876)
1. Appropriate Phosphorus Intake by Parenteral Nutrition Prevents Metabolic Bone Disease of Prematurity in Extremely Low-Birth-Weight Infants. Motokura K; Tomotaki S; Hanaoka S; Yamauchi T; Tomotaki H; Iwanaga K; Niwa F; Takita J; Kawai M JPEN J Parenter Enteral Nutr; 2021 Aug; 45(6):1319-1326. PubMed ID: 32789876 [TBL] [Abstract][Full Text] [Related]
2. Hypophosphatemia as an Early Metabolic Bone Disease Marker in Extremely Low-Birth-Weight Infants After Prolonged Parenteral Nutrition Exposure. Tan YL; Tsao PN; Chou HC; Yen TA; Chen CY JPEN J Parenter Enteral Nutr; 2021 Aug; 45(6):1268-1274. PubMed ID: 32860429 [TBL] [Abstract][Full Text] [Related]
3. Sodium Glycerophosphate Use in Parenteral Nutrition Improves Mineral Metabolism in Extremely Low Birth Weight Infants. Hsu PC; Tsao PN; Chou HC; Huang HC; Yen TA; Chen CY J Pediatr; 2023 Feb; 253():63-71.e2. PubMed ID: 36255046 [TBL] [Abstract][Full Text] [Related]
4. Metabolic bone disease: a continued challenge in extremely low birth weight infants. Viswanathan S; Khasawneh W; McNelis K; Dykstra C; Amstadt R; Super DM; Groh-Wargo S; Kumar D JPEN J Parenter Enteral Nutr; 2014 Nov; 38(8):982-90. PubMed ID: 23963689 [TBL] [Abstract][Full Text] [Related]
5. Don't Forget the Bones: Incidence and Risk Factors of Metabolic Bone Disease in a Cohort of Preterm Infants. Perrone M; Casirati A; Stagi S; Amato O; Piemontese P; Liotto N; Orsi A; Menis C; Pesenti N; Tabasso C; Roggero P; Mosca F Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142579 [TBL] [Abstract][Full Text] [Related]
6. Early high calcium and phosphorus intake by parenteral nutrition prevents short-term bone strength decline in preterm infants. Pereira-da-Silva L; Costa A; Pereira L; Filipe A; Virella D; Leal E; Moreira A; Rosa M; Mendes L; Serelha M J Pediatr Gastroenterol Nutr; 2011 Feb; 52(2):203-9. PubMed ID: 21240015 [TBL] [Abstract][Full Text] [Related]
7. Screening of Serum Alkaline Phosphatase and Phosphate Helps Early Detection of Metabolic Bone Disease in Extremely Low Birth Weight Infants. Zhang H; Jia Q; Piao M; Chang Y; Zhang J; Tong X; Han T Front Pediatr; 2021; 9():642158. PubMed ID: 33968848 [No Abstract] [Full Text] [Related]
8. Screening for Metabolic Bone Disease of prematurity. Rayannavar A; Calabria AC Semin Fetal Neonatal Med; 2020 Feb; 25(1):101086. PubMed ID: 32081592 [TBL] [Abstract][Full Text] [Related]
9. Delayed Introduction of Parenteral Phosphorus Is Associated with Hypercalcemia in Extremely Preterm Infants. Hair AB; Chetta KE; Bruno AM; Hawthorne KM; Abrams SA J Nutr; 2016 Jun; 146(6):1212-6. PubMed ID: 27146915 [TBL] [Abstract][Full Text] [Related]
10. High frequencies of elevated alkaline phosphatase activity and rickets exist in extremely low birth weight infants despite current nutritional support. Mitchell SM; Rogers SP; Hicks PD; Hawthorne KM; Parker BR; Abrams SA BMC Pediatr; 2009 Jul; 9():47. PubMed ID: 19640269 [TBL] [Abstract][Full Text] [Related]
11. Effect of parenteral calcium and phosphorus therapy on mineral retention and bone mineral content in very low birth weight infants. Prestridge LL; Schanler RJ; Shulman RJ; Burns PA; Laine LL J Pediatr; 1993 May; 122(5 Pt 1):761-8. PubMed ID: 8496758 [TBL] [Abstract][Full Text] [Related]
12. Prematurity and bone health. Pieltain C; de Halleux V; Senterre T; Rigo J World Rev Nutr Diet; 2013; 106():181-8. PubMed ID: 23428699 [TBL] [Abstract][Full Text] [Related]
13. Early calcium and phosphorus supplementation in VLBW infants to reduce metabolic bone disease of prematurity: a quality improvement initiative. Krithika MV; Balakrishnan U; Amboiram P; Shaik MSJ; Chandrasekaran A; Ninan B BMJ Open Qual; 2022 Aug; 11(Suppl 1):. PubMed ID: 35995540 [TBL] [Abstract][Full Text] [Related]
14. Relationship of caffeine regimen with osteopenia of prematurity in preterm neonates: a cohort retrospective study. Kumar M; Ali A; Khan MA; Sohail S; Saleem SM; Khan M; Naz F; Khan WA; Salat MS; Hussain K; Ambreen G BMC Pediatr; 2022 Jul; 22(1):437. PubMed ID: 35864501 [TBL] [Abstract][Full Text] [Related]
15. Optimizing parenteral nutrition to achieve an adequate weight gain according to the current guidelines in preterm infants with birth weight less than 1500 g: a prospective observational study. Wang N; Cui L; Liu Z; Wang Y; Zhang Y; Shi C; Cheng Y BMC Pediatr; 2021 Jul; 21(1):303. PubMed ID: 34233641 [TBL] [Abstract][Full Text] [Related]
16. Predictive value of the aspartate aminotransferase to platelet ratio index for parenteral nutrition associated cholestasis in extremely low birth weight infants. Hwang JH; Chung ML BMC Pediatr; 2019 Apr; 19(1):126. PubMed ID: 31018837 [TBL] [Abstract][Full Text] [Related]
17. Continuous versus intermittent bolus infusion of calcium in preterm infants receiving total parenteral nutrition: a randomized blind clinical trial. Shiva S; Rezazadeh K; Amiraslanzadeh A; Mehramuz B; Yeganehdoost S; Mahallei M BMC Pediatr; 2024 Jan; 24(1):35. PubMed ID: 38216920 [TBL] [Abstract][Full Text] [Related]
18. Risk factor analysis of parenteral nutrition-associated cholestasis in extremely low birth weight infants. Lee HH; Jung JM; Nam SH; Lim G; Chung ML Acta Paediatr; 2016 Jul; 105(7):e313-9. PubMed ID: 27097151 [TBL] [Abstract][Full Text] [Related]
19. Effect of early preventive supplementation with calcium and phosphorus on metabolic bone disease in premature infants. Xu X; Ma H; Cheng S; Xue J BMC Pediatr; 2024 Mar; 24(1):171. PubMed ID: 38459481 [TBL] [Abstract][Full Text] [Related]